TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
TScan Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.21−0.02 (-9.00%)
Close on Oct 19, 2026
- Market cap
- $27.32M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of TScan Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 13, 2026 | Oct 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 20, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Apr 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2025 | Nov 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 2, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 30, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 26, 2024 | Dec 26, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 15, 2024 | Nov 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2024 | Nov 1, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 14, 2024 | SEC EDGAR |